With favorable government policies, high-quality talent and an innovative market, German optics giant Zeiss Group is optimistic about the Chinese market, and will continue to invest in the country, ...
ZEISS has introduced the new Aatma, a set of nine high-end full frame T1.5 cinema primes (18mm, 25mm, 35mm, 40mm, 50mm, 65mm, 85mm, 100mm, and 135mm). Designed to marry the benefits of modern optical ...
On Saturday, ZEISS has broken ground on an integrated Greater China headquarters campus in Shanghai’s Waigaoqiao Free Trade Zone, marking its largest single infrastructure investment in China to date.
Investing.com -- Barclays downgraded Carl Zeiss Meditec AG (ETR:AFXG) to “equal weight” from “overweight,” saying the stock’s risk-reward profile has deteriorated after the company withdrew its FY26 ...
Investing.com - Shares of Carl Zeiss Meditec AG slumped in early European trading on Thursday after the German optical technology firm warned that its fiscal first-quarter earnings will be "clearly ...
Ishan Fazili loves gadgets as much he loves cars and bikes. An experienced video producer of more than 9 years in the industry. A full-time media professional and a part time adventure biker. At a ...
Carl Zeiss Meditec is rated a 'Strong Buy' with higher share price target, reflecting significant undervaluation and robust fundamentals. The company achieved over €2.2B in revenue (+7.5% YoY), strong ...
Investing.com -- Carl Zeiss Meditec announced that CEO Maximilian Foerst will step down on December 31 following a violation of the company’s internal Code of Conduct. Shares are down 0.5% today.
Visitors check out medical devices on display at the Zeiss Group booth during the eighth China International Import Expo (CIIE) in Shanghai, Nov 11, 2025. [Photo/VCG] Zeiss Group, a German ...
Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up Chinese tech firm Vivo on Monday launched its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results